SEC Comment Letter 0000000000-25-001312 to iBio, Inc. (IBIO)
iBio, Inc.
Date: Feb. 6, 2025 · CIK: 0001420720 · Accession: 0000000000-25-001312
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284647
Letter
February 6, 2025 Martin Brenner Chief Executive Officer iBio, Inc. 11750 Sorrento Valley Road, Suite 200 San Diego, CA 92121 Re:iBio, Inc. Registration Statement on Form S-3 Filed January 31, 2025 File No. 333-284647 Dear Martin Brenner: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Leslie Marlow, Esq.
Show Raw Text
February 6, 2025
Martin Brenner
Chief Executive Officer
iBio, Inc.
11750 Sorrento Valley Road, Suite 200
San Diego, CA 92121
Re:iBio, Inc.
Registration Statement on Form S-3
Filed January 31, 2025
File No. 333-284647
Dear Martin Brenner:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Leslie Marlow, Esq.